Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome
Key facts
- Who runs it
- Universidad de Burgos
- Where
- Spain1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 32 people enrolled
- Started
- 15 Sept 2025
- Ended
- 30 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Nutrition education
- Supplement
- Placebo
- Record updated
- 30 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Diagnosis: Medical confirmation of Down syndrome (trisomy of chromosome 21)
- Physical capacity: Ability to perform basic physical tests (e.g., standing up from a chair or walking without assistance)
- Informed consent: Informed consent will be obtained from both the participant and their legal representative, in compliance with current legislation for individuals requiring support measures
Who cannot take part
- Chronic kidney disease: Diagnosis of chronic kidney disease
- Allergies or intolerances: Known allergy to creatine or to components of the placebo (inulin)
- Severe motor limitations: Inability to perform the required physical tests (e.g., paralysis or mobility impairments preventing the execution of muscle strength assessments)
- Participation in other studies: Participation in another nutritional or supplementation intervention study within the last 6 months
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Purpose:
Read full original descriptionShow less
This study will test whether 8 weeks of creatine and HMB supplementation can improve muscle strength, body composition, balance, and overall health in people with Down syndrome. Participants will also receive nutrition tips during the study.
Who can participate:
People with Down syndrome who can perform basic physical tasks. Must provide consent from the participant and legal guardian.
What participants will do:
Take creatine (3 g/day) and HMB (3 g/day) or placebo for 8 weeks. Complete tests for muscle strength, balance, and cognitive function. Undergo body composition scans and give blood samples for health markers.
Timing:
All tests and blood samples are taken before and after each 8-week period.
Importance:
Results will help determine if creatine and HMB can safely improve strength, balance, and overall health in people with Down syndrome.
The 2 groups in the trial
- PlaceboExisting treatment, for comparison
Participants will receive placebo supplementation
Treatment: Nutrition education and Placebo
- SupplementationTreatment being tested
Participants will receive creatine monohydrate and beta-hydroxy-beta-methylbutyrate supplementation
Treatment: Nutrition education and Supplement
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 30 October 2026